vs

Side-by-side financial comparison of NGL Energy Partners LP (NGL) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.

NGL Energy Partners LP is the larger business by last-quarter revenue ($909.8M vs $622.0M, roughly 1.5× Royalty Pharma plc). Royalty Pharma plc runs the higher net margin — 34.4% vs 5.2%, a 29.3% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs -41.3%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs -6.4%).

NGL Energy Partners LP is a U.S.-based midstream energy services firm. It offers transportation, storage, and logistics solutions for crude oil, natural gas liquids, and renewable fuels, plus water management services for upstream energy producers, operating primarily across North American markets.

Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.

NGL vs RPRX — Head-to-Head

Bigger by revenue
NGL
NGL
1.5× larger
NGL
$909.8M
$622.0M
RPRX
Growing faster (revenue YoY)
RPRX
RPRX
+46.0% gap
RPRX
4.8%
-41.3%
NGL
Higher net margin
RPRX
RPRX
29.3% more per $
RPRX
34.4%
5.2%
NGL
Faster 2-yr revenue CAGR
RPRX
RPRX
Annualised
RPRX
4.6%
-6.4%
NGL

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
NGL
NGL
RPRX
RPRX
Revenue
$909.8M
$622.0M
Net Profit
$47.2M
$214.2M
Gross Margin
29.0%
Operating Margin
12.1%
62.4%
Net Margin
5.2%
34.4%
Revenue YoY
-41.3%
4.8%
Net Profit YoY
249.3%
2.9%
EPS (diluted)
$0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NGL
NGL
RPRX
RPRX
Q4 25
$909.8M
$622.0M
Q3 25
$674.7M
$609.3M
Q2 25
$622.2M
$578.7M
Q1 25
$971.1M
$568.2M
Q4 24
$982.4M
$593.6M
Q3 24
$756.5M
$564.7M
Q2 24
$759.2M
$537.3M
Q1 24
$1.0B
$568.0M
Net Profit
NGL
NGL
RPRX
RPRX
Q4 25
$47.2M
$214.2M
Q3 25
$29.3M
$288.2M
Q2 25
$68.9M
$30.2M
Q1 25
$13.7M
$238.3M
Q4 24
$13.5M
$208.2M
Q3 24
$2.5M
$544.0M
Q2 24
$9.7M
$102.0M
Q1 24
$-236.8M
$4.8M
Gross Margin
NGL
NGL
RPRX
RPRX
Q4 25
29.0%
Q3 25
37.6%
Q2 25
38.5%
Q1 25
26.9%
Q4 24
25.1%
Q3 24
30.9%
Q2 24
29.0%
Q1 24
21.8%
Operating Margin
NGL
NGL
RPRX
RPRX
Q4 25
12.1%
62.4%
Q3 25
14.0%
70.1%
Q2 25
15.7%
36.3%
Q1 25
8.4%
94.0%
Q4 24
8.6%
60.9%
Q3 24
10.8%
Q2 24
10.8%
50.2%
Q1 24
-9.4%
-13.0%
Net Margin
NGL
NGL
RPRX
RPRX
Q4 25
5.2%
34.4%
Q3 25
4.3%
47.3%
Q2 25
11.1%
5.2%
Q1 25
1.4%
41.9%
Q4 24
1.4%
35.1%
Q3 24
0.3%
96.3%
Q2 24
1.3%
19.0%
Q1 24
-22.8%
0.8%
EPS (diluted)
NGL
NGL
RPRX
RPRX
Q4 25
$0.49
Q3 25
$0.67
Q2 25
$0.07
Q1 25
$0.55
Q4 24
$0.46
Q3 24
$1.21
Q2 24
$0.23
Q1 24
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NGL
NGL
RPRX
RPRX
Cash + ST InvestmentsLiquidity on hand
$6.5M
$618.7M
Total DebtLower is stronger
$2.9B
$9.0B
Stockholders' EquityBook value
$9.7B
Total Assets
$4.4B
$19.6B
Debt / EquityLower = less leverage
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NGL
NGL
RPRX
RPRX
Q4 25
$6.5M
$618.7M
Q3 25
$8.7M
$938.9M
Q2 25
$5.4M
$631.9M
Q1 25
$13.5M
$1.1B
Q4 24
$5.7M
$929.0M
Q3 24
$4.5M
$950.1M
Q2 24
$5.3M
$1.8B
Q1 24
$38.9M
$843.0M
Total Debt
NGL
NGL
RPRX
RPRX
Q4 25
$2.9B
$9.0B
Q3 25
$2.9B
$8.9B
Q2 25
$2.9B
$8.0B
Q1 25
$3.0B
$7.6B
Q4 24
$3.1B
$7.6B
Q3 24
$3.1B
$7.6B
Q2 24
$3.0B
$7.6B
Q1 24
$2.9B
$6.1B
Stockholders' Equity
NGL
NGL
RPRX
RPRX
Q4 25
$9.7B
Q3 25
$9.6B
Q2 25
$9.5B
Q1 25
$9.8B
Q4 24
$10.3B
Q3 24
$10.3B
Q2 24
$9.8B
Q1 24
$9.9B
Total Assets
NGL
NGL
RPRX
RPRX
Q4 25
$4.4B
$19.6B
Q3 25
$4.3B
$19.3B
Q2 25
$4.2B
$18.3B
Q1 25
$4.6B
$17.6B
Q4 24
$4.8B
$18.2B
Q3 24
$4.9B
$18.0B
Q2 24
$4.8B
$17.7B
Q1 24
$5.0B
$16.1B
Debt / Equity
NGL
NGL
RPRX
RPRX
Q4 25
0.92×
Q3 25
0.93×
Q2 25
0.84×
Q1 25
0.78×
Q4 24
0.74×
Q3 24
0.74×
Q2 24
0.78×
Q1 24
0.62×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NGL
NGL
RPRX
RPRX
Operating Cash FlowLast quarter
$182.3M
$827.1M
Free Cash FlowOCF − Capex
$45.7M
FCF MarginFCF / Revenue
5.0%
Capex IntensityCapex / Revenue
15.0%
Cash ConversionOCF / Net Profit
3.86×
3.86×
TTM Free Cash FlowTrailing 4 quarters
$126.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NGL
NGL
RPRX
RPRX
Q4 25
$182.3M
$827.1M
Q3 25
$40.5M
$702.6M
Q2 25
$33.2M
$364.0M
Q1 25
$155.0M
$596.1M
Q4 24
$153.8M
$742.5M
Q3 24
$6.7M
$703.6M
Q2 24
$-18.1M
$658.2M
Q1 24
$152.2M
$664.6M
Free Cash Flow
NGL
NGL
RPRX
RPRX
Q4 25
$45.7M
Q3 25
$9.5M
Q2 25
$11.1M
Q1 25
$60.4M
Q4 24
$152.1M
Q3 24
$-82.9M
Q2 24
$-78.0M
Q1 24
$119.8M
FCF Margin
NGL
NGL
RPRX
RPRX
Q4 25
5.0%
Q3 25
1.4%
Q2 25
1.8%
Q1 25
6.2%
Q4 24
15.5%
Q3 24
-11.0%
Q2 24
-10.3%
Q1 24
11.5%
Capex Intensity
NGL
NGL
RPRX
RPRX
Q4 25
15.0%
Q3 25
4.6%
Q2 25
3.6%
Q1 25
9.7%
Q4 24
0.2%
Q3 24
11.8%
Q2 24
7.9%
Q1 24
3.1%
Cash Conversion
NGL
NGL
RPRX
RPRX
Q4 25
3.86×
3.86×
Q3 25
1.38×
2.44×
Q2 25
0.48×
12.06×
Q1 25
11.29×
2.50×
Q4 24
11.39×
3.57×
Q3 24
2.74×
1.29×
Q2 24
-1.87×
6.45×
Q1 24
139.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NGL
NGL

Water Solutions Segment$208.6M23%
Services$193.3M21%
Butane$192.5M21%
Service Fees$182.8M20%
Public Utilities Inventory Propane$93.9M10%
Crude Oil$23.3M3%
Crude Oil Transportation And Other$6.5M1%
Liquids Logistics Segment$2.5M0%
Crude Oil Logistics Segment$1.2M0%

RPRX
RPRX

Financial Royalty Assets$592.4M95%
Royalty Income Other$29.6M5%

Related Comparisons